Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Daniel, Skiest"'
Autor:
Ivan O. Rosas, Norbert Bräu, Michael Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter, Sanjay Bhagani, Daniel Skiest, Sinisa Savic, Ivor S. Douglas, Julia Garcia-Diaz, Mariam S. Aziz, Nichola Cooper, Taryn Youngstein, Lorenzo Del Sorbo, David J. De La Zerda, Andrew Ustianowski, Antonio Cubillo Gracian, Kevin G. Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick Haslem, Paolo Bonfanti, Cor H. van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Rebecca N. Bauer, Fang Cai, Ivan T. Lee, Balpreet Matharu, Louis Metcalf, Steffen Wildum, Emily Graham, Larry Tsai, Min Bao
Publikováno v:
EClinicalMedicine, Vol 47, Iss , Pp 101409- (2022)
Summary: Background: In COVACTA, a randomised, placebo-controlled trial in patients hospitalised with coronavirus disease-19 (COVID-19), tocilizumab did not improve 28-day mortality, but shortened hospital and intensive care unit stay. Longer-term ef
Externí odkaz:
https://doaj.org/article/0cce1eb2d409455cafdb2877f5cbfad7
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 10, Pp 1956-1958 (2019)
Powassan virus (POWV) encephalitis is a rare tickborne illness. We describe the clinical course, laboratory findings, and imaging for a patient with POWV in Massachusetts, USA. Clinical presentation and laboratory findings were nonspecific. Improveme
Externí odkaz:
https://doaj.org/article/96fa1eb9d1da4e43a068df14b3e78ad7
Autor:
Behzad Etemad, Xiaoming Sun, Yijia Li, Meghan Melberg, Daniela Moisi, Rachel Gottlieb, Hayat Ahmed, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta, Yuko Yuki, Maureen P. Martin, Mary Carrington, Rajesh T. Gandhi, Jeffrey M. Jacobson, Paul Volberding, Elizabeth Connick, Ronald Mitsuyasu, Ian Frank, Michael Saag, Joseph J. Eron, Daniel Skiest, David M. Margolis, Diane Havlir, Robert T. Schooley, Michael M. Lederman, Xu G. Yu, Jonathan Z. Li
Publikováno v:
Proceedings of the National Academy of Sciences. 120
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after stopping antiretroviral therapy (ART). Understanding the mechanisms of HIV post-treatment control will inform development of strategies aiming at achi
Autor:
Adam Wedrychowski, Holly Anne Martin, Yijia Li, Sushama Telwatte, Gayatri Nikhila Kadiyala, Meghan Melberg, Behzad Etemad, Elizabeth Connick, Jeffrey M. Jacobson, David M. Margolis, Daniel Skiest, Paul Volberding, Frederick Hecht, Steven Deeks, Joseph K. Wong, Jonathan Z. Li, Steven A. Yukl
Publikováno v:
Journal of virology, vol 97, iss 1
J Virol
J Virol
Posttreatment controllers (PTCs) are rare HIV-infected individuals who can limit viral rebound after antiretroviral therapy interruption (ATI), but the mechanisms of this remain unclear. To investigate these mechanisms, we quantified various HIV RNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa36ec8558bac4429575ecaf8fecdb4
https://escholarship.org/uc/item/9zv2x2rv
https://escholarship.org/uc/item/9zv2x2rv
Autor:
Fatima Warraich, Syed Hamza Sohail, Jacob Smith, Alexander Knee, Hans Schlecht, Daniel Skiest
Publikováno v:
American Journal of Gastroenterology. 117:e159-e160
Autor:
Ivan O. Rosas, Norbert Bräu, Michael Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter, Sanjay Bhagani, Daniel Skiest, Sinisa Savic, Ivor S. Douglas, Julia Garcia-Diaz, Mariam S. Aziz, Nichola Cooper, Taryn Youngstein, Lorenzo Del Sorbo, David J. De La Zerda, Andrew Ustianowski, Antonio Cubillo Gracian, Kevin G. Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick Haslem, Paolo Bonfanti, Cor H. van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Rebecca N. Bauer, Fang Cai, Ivan T. Lee, Balpreet Matharu, Louis Metcalf, Steffen Wildum, Emily Graham, Larry Tsai, Min Bao
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Rosas, I O, Bräu, N, Waters, M, Go, R C, Malhotra, A, Hunter, B D, Bhagani, S, Skiest, D, Savic, S, Douglas, I S, Garcia-Diaz, J, Aziz, M S, Cooper, N, Youngstein, T, Sorbo, L D, De La Zerda, D J, Ustianowski, A, Gracian, A C, Blyth, K G, Carratalà, J, François, B, Benfield, T, Haslem, D, Bonfanti, P, van der Leest, C H, Rohatgi, N, Wiese, L, Luyt, C E, Bauer, R N, Cai, F, Lee, I T, Matharu, B, Metcalf, L, Wildum, S, Graham, E, Tsai, L & Bao, M 2022, ' Tocilizumab in patients hospitalised with COVID-19 pneumonia : Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) ', EClinicalMedicine, vol. 47, 101409 . https://doi.org/10.1016/j.eclinm.2022.101409
Universidad de Barcelona
Rosas, I O, Bräu, N, Waters, M, Go, R C, Malhotra, A, Hunter, B D, Bhagani, S, Skiest, D, Savic, S, Douglas, I S, Garcia-Diaz, J, Aziz, M S, Cooper, N, Youngstein, T, Sorbo, L D, De La Zerda, D J, Ustianowski, A, Gracian, A C, Blyth, K G, Carratalà, J, François, B, Benfield, T, Haslem, D, Bonfanti, P, van der Leest, C H, Rohatgi, N, Wiese, L, Luyt, C E, Bauer, R N, Cai, F, Lee, I T, Matharu, B, Metcalf, L, Wildum, S, Graham, E, Tsai, L & Bao, M 2022, ' Tocilizumab in patients hospitalised with COVID-19 pneumonia : Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) ', EClinicalMedicine, vol. 47, 101409 . https://doi.org/10.1016/j.eclinm.2022.101409
Background: \ud In COVACTA, a randomised, placebo-controlled trial in patients hospitalised with coronavirus disease-19 (COVID-19), tocilizumab did not improve 28-day mortality, but shortened hospital and intensive care unit stay. Longer-term effects
Autor:
Michael B Rothberg, Penelope S Pekow, Aruna Priya, Marya D Zilberberg, Raquel Belforti, Daniel Skiest, Tara Lagu, Thomas L Higgins, Peter K Lindenauer
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87382 (2014)
BACKGROUND:Mortality prediction models generally require clinical data or are derived from information coded at discharge, limiting adjustment for presenting severity of illness in observational studies using administrative data. OBJECTIVES:To develo
Externí odkaz:
https://doaj.org/article/cd43fbae41e84eebb5b08cbc21f09728
Autor:
Lorenzo Del Sorbo, Atul Malhotra, Larry Tsai, Helen Spotswood, Ronaldo C. Go, Ivan O. Rosas, Taryn Youngstein, Norbert Bräu, Andrew Ustianowski, Sanjay Bhagani, Min Bao, Sophie Dimonaco, Mariam Aziz, Nichola Cooper, Bradley D Hunter, David J. De La Zerda, Michael F. Waters, Daniel Skiest, Emily Graham, Sinisa Savic, Antonio Cubillo Gracian, Balpreet Matharu, Ivor S. Douglas
Publikováno v:
The New England journal of medicine, vol 384, iss 16
Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b63ca1c20584d448f33fd98ff7b410f
https://escholarship.org/uc/item/36k8m3wp
https://escholarship.org/uc/item/36k8m3wp
Autor:
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Andrea Antinori, Roberto Ortiz, Amanda E Clarke, Chien-Ching Hung, Jürgen K Rockstroh, Pierre-Marie Girard, Jörg Sievers, Choy Man, Alexander Currie, Mark Underwood, Allan R Tenorio, Keith Pappa, Brian Wynne, Anna Fettiplace, Martin Gartland, Michael Aboud, Kimberly Smith, Lidia Cassetti, Daniel David, Laura Figueras, Marcelo Losso, Gustavo Lopardo, Sergio Lupo, Norma Porteiro, Marisa Sánchez, Mark Bloch, David Cooper, Robert Finlayson, Anthony Kelleher, Kenneth Koh, David Lewis, James McMahon, Richard Moore, Norman Roth, Matthew Shields, Stephane De Wit, Eric Florence, Jean-Christophe Goffard, Remy Demeester, Patrick Lacor, Bernard Vandercam, Linos Vandekerckhove, Jonathan Angel, Jean-Guy Baril, Brian Conway, Alexandra De Pokomandy, Jason Szabo, Sharon Walmsley, Olivier Bouchaud, Christian Chidiac, Pierre Delobel, Cecile Goujard, Christine Katlama, Jean-Michel Molina, Gilles Pialoux, Patrick Philibert, Johannes Bogner, Stefan Esser, Ivanka Krznaric, Clara Lehmann, Christoph Spinner, Hans-Jurgen Stellbrink, Christoph Stephan, Albrecht Stoehr, Enrico Barchi, Pietro Caramello, Francesco Castelli, Anna Maria Cattelan, Antonella D'Arminio Monforte, Antonio Di Biagio, Giovanni Di Perri, Andrea Gori, Franco Maggiolo, Barbara Menzaghi, Guglielmo Migliorino, Cristina Mussini, Giovanni Penco, Massimo Puoti, Giuliano Rizzardini, Roberto Gulminetti, Adriano Lazzarin, Tiziano Quirino, Laura Sighinolfi, Pierluigi Viale, Gerardo Amaya Tapia, Jaime Andrade Villanueva, Enrique R Granados Reyes, Alma Perez Rios, Mario Santoscoy Gomez, Jan Den Hollander, Bart Rijnders, José A Hidalgo, Luis Hercilla Vasquez, Luis Illescas, Anita Olczak, Kamal Mansinho, Patricia Paula Correia Pacheco, Eugénio Teófilo, Jose Saraiva da Cunha, Rui Sarmento e Castro, Rosário Serrão, Manuela Arbune, Cristian Jianu, Anca Oprea, Liliana Preotescu, Liviu-Jany Prisacariu, Elena Belonosova, Olga Borodkina, Oxana Chernova, Natalia Gankina, Svetlana Kizhlo, Valeriy Kulagin, Nadezhda Kurina, Firaya Nagimova, Vadim Pokrovsky, Elena Ryamova, Evgeny Voronin, Alexey Yakovlev, Richard Kaplan, Sun Hee Lee, Shin-Woo Kim, Sang-Il Kim, Woo Joo Kim, Antonio Antela Lopez, Jose L Casado Osorio, Manuel A Castaño Carracedo, Ignacio De Los Santos Gil, Vicente Estrada Perez, Vicenç Falco Ferrer, Luis Force, Maria Jose Galinda Puerto, Miguel Garcia Deltoro, Josep M Gatell, Miguel A Goenaga Sanchez, Ana González Cordón, Hernando Knobel, Juan Carlos Lopez Bernaldo de Quiros, Juan E Losa Garcia, Mar Masia, Marta Montero-Alsonso, Antonio Ocampo Hermida, Juan Pasquau Liaño, Joaquin Portilla Sogorb, Federico Pulido Ortega, Antonio Rivera Roman, Jose Ramon Santos Fernandez, Rafael Torres Perea, Jesus Troya Garcia, Pompeyo Viciana Fernandez, Alexandra Calmy, Christoph Hauser, Jan Fehr, Shu-Hsing Cheng, Wen-Chien Ko, Hsi-Hsun Lin, Po-Liang Lu, Yu-Ting Tseng, Ning-Chi Wang, Wing-Wai Wong, Chia-Jui Yang, Roberto Arduino, Paul Benson, Mezgebe Berhe, Fritz Bredeek, Cynthia Brinson, Thomas Campbell, Gordon Crofoot, Douglas Cunningham, Edwin DeJesus, Robin Dretler, Joseph Eron, Kenneth Fife, Carl Fichtenbaum, Jason Flamm, Deborah Goldstein, Samir Gupta, Debbie Hagins, Margaret Hoffman-Terry, Dushyantha Jayaweera, Clifford Kinder, Daniel Klein, Cheryl McDonald, Anthony Mills, Ronald Nahass, Olayemi Osiyemi, Edgar Overton, David Parks, David Prelutsky, Moti Ramgopal, Shannon Schrader, Beverly Sha, Gary Simon, James Sims, Daniel Skiest, Jihad Slim, Karen Tashima, Blair Thedinger, Brian Gazzard, Julie Fox, Margaret Johnson, Stephen Kegg, Saye Khoo, Charles Mazhude, Chloe Orkin, Gabriel Schembri, Andrew Ustianowski
Publikováno v:
The Lancet, 393(10167), 143-155. Elsevier Ltd.
Summary Background Effective two-drug regimens could decrease long-term drug exposure and toxicity with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and safety of a two-drug regimen compared with a three-drug regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad70b60db548619c808fac0879d6106
https://hdl.handle.net/11380/1221490
https://hdl.handle.net/11380/1221490
Publikováno v:
The AIDS reader. 19(1)
We report a case of subacute onset of paraparesis in a patient with AIDS. Empiric treatment for toxoplasmosis of the brain and the spinal cord resulted in resolution of the paraparesis. This case highlights the differential diagnosis of toxoplasmosis